International Stem Cell (ISCO) EPS (Basic) (QoQ) (2010 - 2025)
Powered by 
Analysis
International Stem Cell (ISCO) EPS (Basic) (QoQ) (2010 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.37 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.03 Bn | 5.03 Bn | - |
| 3 | Iovance Biotherapeutics | 3.66 Bn | 3.36 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn |
| 5 | uniQure | 2.99 Bn | 2.99 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.52 Bn | 2.52 Bn | - |
| 7 | Precigen | 2.38 Bn | 2.38 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.15 Bn | 1.35 Bn | 251.87 Mn |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn |
| 10 | International Stem Cell | 3.60 Mn | 2.51 Mn | 1.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -1,300.00% |
| Sep 30, 2025 | -56.72% |
| Jun 30, 2025 | 126.17% |
| Mar 31, 2025 | -2,233.33% |
| Dec 31, 2024 | 109.60% |
| Sep 30, 2024 | -301.61% |
| Jun 30, 2024 | 128.97% |
| Mar 31, 2024 | 53.28% |
| Dec 31, 2023 | -249.62% |
| Sep 30, 2023 | -150.58% |
| Jun 30, 2023 | 861.73% |
| Mar 31, 2023 | -221.43% |
| Dec 31, 2022 | 108.16% |
| Sep 30, 2022 | -17,050.00% |
| Jun 30, 2022 | 77.78% |
| Mar 31, 2022 | 97.58% |
| Dec 31, 2021 | 41.97% |
| Sep 30, 2021 | -39.78% |
| Jun 30, 2021 | 27.89% |
| Mar 31, 2021 | 21.29% |